Department of Medicine 5 – Haematology and Oncology

Effective treatment of low-risk acute GVHD with itacitinib monotherapy (2023) Etra A, Capellini A, Alousi A, Al Malki MM, Choe H, DeFilipp Z, Hogan WJ, et al. Journal article Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma-Data from a Population-Based Cohort Study Applying Propensity Score Matching (2023) Spoerl S, Gerken M, Fischer R, Spörl S, Kirschneck C, Wolf S, Taxis J, et al. Journal article Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia (2023) Hoffmann J, Eminovic S, Wilhelm C, Krause S, Neubauer A, Thrun MC, Ultsch A, Brendel C Journal article A Practical Approach to Systemic Mastocytosis Complications in Cardiac Surgery: A Case Report and Systematic Review of the Literature (2023) Suleiman M, Brückl V, Fechner J, Kaemmerer AS, Wilk F, Weyand M, Harig F Journal article, Review article A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma (2023) Spoerl S, Erber R, Gerken M, Taxis J, Ludwig N, Nieberle F, Biermann N, et al. Journal article Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. (2023) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article, Erratum Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL (2023) Blumenberg V, Busch G, Baumann S, Jitschin R, Iacoboni G, Gallur L, Iraola-Truchuelo J, et al. Journal article Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia (2023) Eckardt JN, Stasik S, Röllig C, Petzold A, Sauer T, Scholl S, Hochhaus A, et al. Journal article CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial (2023) Mackensen A, Haanen JB, Koenecke C, Alsdorf W, Wagner-Drouet E, Borchmann P, Heudobler D, et al. Journal article Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study (2023) Gerbitz A, Gary R, Aigner M, Moosmann A, Kremer A, Schmid C, Hirschbuehl K, et al. Journal article